Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8383360
Methods of diagnosing and treating autism
granted patentUS 8383132
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods
granted patentUS 8378109
Labeled ALPHA4BETA2 ligands and methods therefor
granted patentUS 8378084
Fusion molecule based on novel TAA variant
granted patentUS 8372826
Estriol therapy for multiple sclerosis and other autoimmune diseases
granted patentUS 8372848
Melanin-concentrating hormone receptor antagonists and methods of use
granted patentUS 8372380
In vivo imaging of sulfotransferases
granted patentUS 8361756
Bifidobacterial gene sequences and their use
granted patentUS 8361982
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a
granted patentUS 8361733
Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and reco
granted patentUS 8357374
Conjugates of synthetic TLR agonists and uses therefor
granted patentUS 8357365
Granulysin peptides and methods of use thereof
granted patentUS 8354538
Small-molecule inhibitors of the androgen receptor
granted patentUS 8349353
Controlled release cytotoxic agent compositions and methods for the treatment of otic diso
granted patentUS 8350042
Antiviral compounds for the treatment of HCV infection
granted patentUS 8349910
Aldehyde tags, uses thereof in site-specific protein modification
granted patentUS 8348921
Gels with predetermined conductivity used in electroporation of tissue
granted patentUS 8337866
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamy
granted patentUS 8329873
Bispecific single chain Fv antibody molecules and methods of use thereof
granted patentUS 8329636
Carcinoma diagnosis and treatment, based on ODC1 genotype
granted patentUS 8324178
Method of treatment using alpha-1-adrenergic agonist compounds
granted patentUS 8324192
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal trac
granted patentUS 8324169
VEGF-activated ligands
granted patentUS 8318700
Lung-targeted drugs
granted